Commitments and Contingencies (Details Textual) - USD ($) |
1 Months Ended | 3 Months Ended | 9 Months Ended | 12 Months Ended | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jan. 14, 2014 |
Dec. 31, 2015 |
Mar. 31, 2017 |
Mar. 31, 2016 |
Mar. 31, 2017 |
Mar. 31, 2016 |
Jun. 30, 2016 |
Jun. 30, 2015 |
Sep. 01, 2014 |
Apr. 30, 2014 |
Dec. 30, 2013 |
Nov. 30, 2013 |
Apr. 30, 2013 |
|
| Commitments and Contingencies [Line Items] | |||||||||||||
| Research and Development Expense, Total | $ 1,136,000 | $ 1,048,000 | $ 3,005,000 | $ 2,303,000 | $ 3,156,000 | $ 3,495,000 | |||||||
| Royalty Guarantees, Commitments, Amount | $ 200,000 | ||||||||||||
| Long Term Purchase Commitment Expire Date | Dec. 31, 2015 | ||||||||||||
| Settlement Liabilities, Current | $ 1,875,000 | ||||||||||||
| Commitments [Member] | |||||||||||||
| Commitments and Contingencies [Line Items] | |||||||||||||
| Research Services Agreements Value Fulfilling Commitment | $ 3,000,000 | ||||||||||||
| Research and Development Expense, Total | 2,700,000 | ||||||||||||
| License Costs | $ 30,627 | ||||||||||||
| Initial license fee | 20,000 | ||||||||||||
| Contractual Obligation, Due in Next Twelve Months | $ 78,000 | ||||||||||||
| Contractual Obligation, Due in Second Year | $ 161,754 | ||||||||||||
| Settlement Agreement [Member] | |||||||||||||
| Commitments and Contingencies [Line Items] | |||||||||||||
| Prepaid Expense | $ 1,000,000 | $ 1,000,000 | $ 1,000,000 | ||||||||||
| Amended Agreement [Member] | |||||||||||||
| Commitments and Contingencies [Line Items] | |||||||||||||
| Research and Development Expense, Total | $ 2,100,000 | ||||||||||||
| Second Eastern Affilate [Member] | iBio CMO LLC [Member] | |||||||||||||
| Commitments and Contingencies [Line Items] | |||||||||||||
| Lease Term | 34 years | 34 years | |||||||||||
| Minimum [Member] | Commitments [Member] | |||||||||||||
| Commitments and Contingencies [Line Items] | |||||||||||||
| License Costs | 25,000 | ||||||||||||
| Maximum [Member] | Commitments [Member] | |||||||||||||
| Commitments and Contingencies [Line Items] | |||||||||||||
| License Costs | $ 150,000 | ||||||||||||
| Fraunhofer [Member] | |||||||||||||
| Commitments and Contingencies [Line Items] | |||||||||||||
| Royalty Guarantees, Commitments, Amount | $ 3,000,000 | $ 4,000,000 | $ 4,000,000 | $ 4,000,000 | |||||||||
| Other Commitments, Description | under the terms of the TTA and for a period of 15 years, the Company shall pay Fraunhofer one percent (1%) of all receipts derived by the Company from sales of products produced utilizing the iBioLaunch or iBioModulator technology and ten percent (10%) of all receipts derived by the Company from licensing either of those technologies to third parties. | under the terms of the TTA and for a period of 15 years, the Company shall pay Fraunhofer one percent (1%) of all receipts derived by the Company from sales of products produced utilizing the iBioLaunch or iBioModulator technology and ten percent (10%) of all receipts derived by the Company from licensing either of those technologies to third parties. | |||||||||||